Cargando…
Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma
Osteosarcoma is a common malignant bone tumor in children and adolescents. The current 5-year survival rate is ~60% and that seems to be reaching a plateau. In order to improve treatment outcomes of osteosarcoma, a better understanding of tumorigenesis and underlying molecular mechanisms is required...
Autores principales: | Pruksakorn, Dumnoensun, Teeyakasem, Pimpisa, Klangjorhor, Jeerawan, Chaiyawat, Parunya, Settakorn, Jongkolnee, Diskul-Na-Ayudthaya, Penchatr, Chokchaichamnankit, Daranee, Pothacharoen, Peraphan, Srisomsap, Chantragan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948955/ https://www.ncbi.nlm.nih.gov/pubmed/27573585 http://dx.doi.org/10.3892/ijo.2016.3601 |
Ejemplares similares
-
Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway
por: Chaiyawat, Parunya, et al.
Publicado: (2019) -
Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
por: Chaiyawat, Parunya, et al.
Publicado: (2018) -
Exploring targeted therapy of osteosarcoma using proteomics data
por: Chaiyawat, Parunya, et al.
Publicado: (2017) -
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017)